Fundz

Who to call at Alnylam Pharmaceuticals, and when

Fundz watches for the moments Alnylam Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Alnylam Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alnylam Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alnylam Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Alnylam Pharmaceuticals Partners with Inceptive Nucleics to Enhance RNAi Drug Discovery Using AI.

Jun 04, 2026

Contract Type

partnership

CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Alnylam Pharmaceuticals has entered a partnership with AI firm Inceptive Nucleics to accelerate RNAi drug discovery through generative AI models. This collaboration aims to improve research productivity and contribute to Alnylam's strategic goals for the future.

Company Information

Company

Alnylam Pharmaceuticals

Location

Cambridge, Massachusetts, United States

About

Alnylam Pharmaceuticals, Inc. is a leading RNAi therapeutics company focused on developing novel medicines to treat genetically defined diseases. The company is committed to bringing innovative treatments to patients suffering from serious conditions. Their investigational product vutrisiran is designed to treat transthyretin amyloidosis with cardiomyopathy, aiming to improve patient outcomes through advanced therapeutic approaches.

Related People

Pushkal
Likely contact at this company
••••••••@••••••••

See Pushkal's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Alnylam Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Alnylam Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.